Julie A. Lynch, PhD, RN, MBA

Article

Differences in Prognostic Value of FLT3 and NPM1 Mutations in Patients With Acute Myeloid Leukemia

Author:: Julie A. Lynch, PhD, RN, MBA

Publish date: August 5, 2026

Acute myeloid leukemia (AML) is an aggressive hematologic malignancy that, when left untreated, rapidly leads to death.

Article

In Reference to: “Cost and Utility of Thrombophilia Testing”

Author:: Julie A. Lynch, PhD, RN, MBA

Publish date: August 23, 2017

1Department of Veterans Affairs, Salt Lake City Health Care System, Salt Lake City, Utah; 2School of Medicine, Boston University, Boston, Massachus...